Beverly Hills 12/2/2009 1:11:43 AM
News / Business

Swiss Competition Regulators Fine Three Firms $5.7 Million for Price-Fixing

Finance World News Update by EQUITIES Magazine

Swiss competition regulators fined the Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG for alleged price fixing of erectile dysfunction drugs. The three companies rejected the allegation.

 

Viagra, Cialis and Levitra were fixed in the form of public price recommendations, said the Swiss Competition Commission. The Commission didn’t specify how much each company was fined, and a competition spokesman declined to provide the information.

 

About EQUITIES:

 

Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.

 

Sign up for a free one-year subscription to EQUITIES Magazine